Cargando…

Peroxiredoxins in Neurodegenerative Diseases

Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance...

Descripción completa

Detalles Bibliográficos
Autor principal: Szeliga, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761365/
https://www.ncbi.nlm.nih.gov/pubmed/33265993
http://dx.doi.org/10.3390/antiox9121203
_version_ 1783627551710642176
author Szeliga, Monika
author_facet Szeliga, Monika
author_sort Szeliga, Monika
collection PubMed
description Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS/RNS defense systems. An increasing number of studies suggests that these enzymes may be involved in the neurodegenerative process. This article reviews the current knowledge on the expression and putative roles of PRDXs in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and dementia with Lewy bodies, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease.
format Online
Article
Text
id pubmed-7761365
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77613652020-12-26 Peroxiredoxins in Neurodegenerative Diseases Szeliga, Monika Antioxidants (Basel) Review Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS/RNS defense systems. An increasing number of studies suggests that these enzymes may be involved in the neurodegenerative process. This article reviews the current knowledge on the expression and putative roles of PRDXs in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and dementia with Lewy bodies, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease. MDPI 2020-11-30 /pmc/articles/PMC7761365/ /pubmed/33265993 http://dx.doi.org/10.3390/antiox9121203 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szeliga, Monika
Peroxiredoxins in Neurodegenerative Diseases
title Peroxiredoxins in Neurodegenerative Diseases
title_full Peroxiredoxins in Neurodegenerative Diseases
title_fullStr Peroxiredoxins in Neurodegenerative Diseases
title_full_unstemmed Peroxiredoxins in Neurodegenerative Diseases
title_short Peroxiredoxins in Neurodegenerative Diseases
title_sort peroxiredoxins in neurodegenerative diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761365/
https://www.ncbi.nlm.nih.gov/pubmed/33265993
http://dx.doi.org/10.3390/antiox9121203
work_keys_str_mv AT szeligamonika peroxiredoxinsinneurodegenerativediseases